Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6306)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2015 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim DH, Yun HY, Ryu DH, Han HS, Han JH, Yoon SM, Youn SJ. Preoperative CA 125 is significant indicator of curative resection in gastric cancer patients. World J Gastroenterol 2015; 21(4): 1216-1221 [PMID: 25632195 DOI: 10.3748/wjg.v21.i4.1216] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i4/1216.htm |
| Number | Citing Articles |
| 1 |
Taobo Luo, Wenhu Chen, Lifang Wang, Hongguang Zhao. CA125 is a potential biomarker to predict surgically incurable gastric and cardia cancer. Medicine 2016; 95(51): e5297 doi: 10.1097/MD.0000000000005297
|
| 2 |
N. N. Semenov, K. D. Dalgatov. Elevated levels of CA125 (MUC16) in metastatic gastric cancer as a strong predictor of poor survival. Malignant tumours 2022; 12(1): 44 doi: 10.18027/2224-5057-2022-12-1-44-50
|
| 3 |
O. I. Kit, E. M. Frantsiyants, I. V. Kaplieva, Yu. A. Gevorkyan, N. V. Soldatkina, E. A. Dzhenkova, N. S. Samoylenko, Yu. A. Pogorelova. Levels of oncofetal proteins in pathological tissues of patients with gastric cancer. Experimental and Clinical Gastroenterology 2020; (9): 50 doi: 10.31146/1682-8658-ecg-169-9-50-55
|
| 4 |
Tiezhu Ren, Wenjuan Zhang, Shenglin Li, Liangna Deng, Caiqiang Xue, Zhengxiao Li, Suwei Liu, Jiachen Sun, Junlin Zhou. Combination of clinical and spectral-CT parameters for predicting lymphovascular and perineural invasion in gastric cancer. Diagnostic and Interventional Imaging 2022; 103(12): 584 doi: 10.1016/j.diii.2022.07.004
|
| 5 |
Jin Moriyama, Hideaki Shimada, Yoko Oshima, Takashi Suzuki, Satoshi Yajima, Fumiaki Shiratori, Kimihiko Funahashi. Prognostic Impact of Perioperative CA125 Status in Gastric Cancer Based on New Cutoff Values. Cureus 2024; doi: 10.7759/cureus.61609
|
| 6 |
Ai-Hua Sun, Xin-Yu Zhang, Yang-Yang Huang, Lei Chen, Qing Wang, Xiao-Cong Jiang. Prognostic value and predictive model of tumor markers in stage I to III gastric cancer patients. World Journal of Clinical Oncology 2024; 15(8): 1033-1047 doi: 10.5306/wjco.v15.i8.1033
|
| 7 |
Ilaria Benevento, Nadia Bulzonetti, Francesca De Felice, Daniela Musio, Massimo Vergine, Vincenzo Tombolini. The role of different adjuvant therapies in locally advanced gastric adenocarcinoma. Oncotarget 2018; 9(74): 34022 doi: 10.18632/oncotarget.26106
|
| 8 |
Chao Yang, Yujie Yang, Xiaodong Huang, HuaLi Li, Huangrong Cheng, Shilun Tong, Yongbin Zheng, Marcello Ciaccio. A Nomogram Based on Clinicopathologic Features and Preoperative Hematology Parameters to Predict Occult Peritoneal Metastasis of Gastric Cancer: A Single-Center Retrospective Study. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/1418978
|
| 9 |
Tsutomu Namikawa, Yasuhiro Kawanishi, Kazune Fujisawa, Eri Munekage, Jun Iwabu, Masaya Munekage, Hiromichi Maeda, Hiroyuki Kitagawa, Michiya Kobayashi, Kazuhiro Hanazaki. Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer. Surgery Today 2018; 48(4): 388 doi: 10.1007/s00595-017-1598-3
|
| 10 |
Yao Huang, Jianxing Zeng, Teng Liu, Xinju Lin, Pengfei Guo, Jinhua Zeng, Weiping Zhou, Jingfeng Liu. <p>Prognostic Significance of Elevated Preoperative Serum CA125 Levels After Curative Hepatectomy for Hepatocellular Carcinoma</p>. OncoTargets and Therapy 2020; : 4559 doi: 10.2147/OTT.S236475
|
| 11 |
Sho Sato, Tomomi Kato, Kenji Abe, Tatsuya Hanaoka, Yuri Yano, Akira Kurosaki, Masanori Yasuda, Tetsuo Sekino, Keiichi Fujiwara, Kosei Hasegawa. Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression. Oncology Letters 2017; 14(1): 776 doi: 10.3892/ol.2017.6254
|
| 12 |
Jie Zou, Yan-Kun Shen, Shi-Nan Wu, Hong Wei, Qing-Jian Li, San Hua Xu, Qian Ling, Min Kang, Zhao-Lin Liu, Hui Huang, Xu Chen, Yi-Xin Wang, Xu-Lin Liao, Gang Tan, Yi Shao. Prediction Model of Ocular Metastases in Gastric Adenocarcinoma: Machine Learning-Based Development and Interpretation Study. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338231219352
|
| 13 |
Boduan Xiao, Leilei Zhang, Huihui Liu, Huiling Fang, Chunming Wang, Biao Huang, Xinyuan Liu, Xiumei Zhou, Yigang Wang. Oncolytic Adenovirus CD55-Smad4 Suppresses Cell Proliferation, Metastasis, and Tumor Stemness in Colorectal Cancer by Regulating Wnt/β-Catenin Signaling Pathway. Biomedicines 2020; 8(12): 593 doi: 10.3390/biomedicines8120593
|
| 14 |
LIANG LIU, JINFENG XIANG, RUFU CHEN, DELIANG FU, DEFEI HONG, JIHUI HAO, YIXIONG LI, JIANGTAO LI, SHENGPING LI, YIPING MOU, GANG MAI, QUANXING NI, LI PENG, RENYI QIN, HONGGANG QIAN, CHENGHAO SHAO, BEI SUN, YONGWEI SUN, MIN TAO, BOLE TIAN, HONGXIA WANG, JIAN WANG, LIWEI WANG, WEI WANG, WEILIN WANG, JUN ZHANG, GANG ZHAO, JUN ZHOU, XIANJUN YU. The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC). International Journal of Oncology 2016; 48(3): 900 doi: 10.3892/ijo.2015.3316
|
| 15 |
Ze-Ping Huang, Wen-Jun Zhang, Zi-Xian Wang, Hai-Peng Liu, Xiang-Ting Zeng, Kang Chen, Mei Li, Zhao-Feng Chen, Dong-Sheng Zhang, Xiao Chen. Prognostic Performance of Three Lymph Node Staging Systems in Patients After D2 Lymphadenectomy for Gastric Cancer. International Surgery 2023; 107(2): 61 doi: 10.9738/INTSURG-D-15-00250.1
|
| 16 |
Yilin Tong, Yan Zhao, Zexing Shan, Jianjun Zhang. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07666-8
|
| 17 |
Akira Kurosaki, Kosei Hasegawa, Tomomi Kato, Kenji Abe, Tatsuya Hanaoka, Akiko Miyara, Daniel J. O'Shannessy, Elizabeth B. Somers, Masanori Yasuda, Tetsuo Sekino, Keiichi Fujiwara. Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression. International Journal of Cancer 2016; 138(8): 1994 doi: 10.1002/ijc.29937
|
| 18 |
Linda Agolli, Riccardo Maurizi Enrici, Mattia Falchetto Osti. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?. World Journal of Gastroenterology 2016; 22(3): 1131-1138 doi: 10.3748/wjg.v22.i3.1131
|